| |
| |
|
| Insider
Information: |
Monia Brett P |
| Relationship: |
Director |
| City: |
Carlsbad |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
188,789 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$7,084,848 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
188,789 |
|
|
| Total
Value |
$7,084,848 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
9
|
|
Stock
price went up :
|
0
|
2
|
| Stock
price went down : |
0
|
7
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -81.6%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Ionis Pharmaceuticals Inc |
IONS |
CEO Level 15, Director |
2024-02-29 |
174,289 |
2012-01-01 |
0 |
Premium* |
|
|
Cognition Therapeutics Inc |
CGTX |
Director |
2024-06-07 |
14,500 |
2023-06-09 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
117 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 5 of 5
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| IONS |
Ionis Pharmaceuticals Inc |
Chief Operating Officer |
• – – |
2019-01-02 |
4 |
AS |
$53.50 |
$11,449 |
D/D |
(214) |
15,837 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chief Executive Officer |
• • – |
2020-09-01 |
4 |
AS |
$53.70 |
$16,862 |
D/D |
(314) |
28,879 |
0 |
% |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chief Operating Officer |
• – – |
2018-08-27 |
4 |
AS |
$54.00 |
$890,622 |
D/D |
(16,493) |
15,841 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chief Executive Officer |
• • – |
2021-03-01 |
4 |
AS |
$54.28 |
$12,809 |
D/D |
(236) |
50,114 |
0 |
% |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chief Operating Officer |
• – – |
2018-11-23 |
4 |
AS |
$55.00 |
$1,870,058 |
D/D |
(34,000) |
15,841 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Drug Discovery |
• – – |
2015-07-02 |
4 |
AS |
$56.30 |
$11,147 |
D/D |
(198) |
4,355 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chief Operating Officer |
• – – |
2019-01-15 |
4 |
D |
$58.26 |
$208,105 |
D/D |
(3,572) |
22,275 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
COO & SVP, Translational Med |
• • – |
2019-11-20 |
4 |
AS |
$60.01 |
$346,618 |
D/D |
(5,776) |
16,458 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chief Executive Officer |
• • – |
2020-01-02 |
4 |
AS |
$60.25 |
$10,423 |
D/D |
(173) |
16,285 |
0 |
% |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chief Executive Officer |
• • – |
2021-01-28 |
4 |
D |
$60.69 |
$79,261 |
D/D |
(1,306) |
50,103 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Drug Discovery |
• – – |
2016-01-04 |
4 |
AS |
$61.00 |
$7,747 |
D/D |
(127) |
4,358 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chief Executive Officer |
• • – |
2021-01-15 |
4 |
D |
$61.28 |
$914,727 |
D/D |
(14,927) |
48,775 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chief Executive Officer |
• • – |
2020-01-15 |
4 |
D |
$62.06 |
$469,360 |
D/D |
(7,563) |
28,643 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Drug Discovery |
• – – |
2015-01-02 |
4 |
AS |
$62.75 |
$4,769 |
D/D |
(76) |
1,935 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Drug Discovery |
• – – |
2015-06-08 |
4 |
AS |
$66.22 |
$503,280 |
D/D |
(7,600) |
4,426 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chief Operating Officer |
• • – |
2019-07-02 |
4 |
AS |
$66.40 |
$13,944 |
D/D |
(210) |
22,234 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Drug Discovery |
• – – |
2015-01-16 |
4 |
S |
$67.96 |
$104,257 |
D/D |
(1,534) |
4,426 |
0 |
- |
|
117 Records found
|
|
Page 5 of 5 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
